{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:01Z","timestamp":1786997821906,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Eleanor and Scott Petty Fund","award":["CA016672"],"award-info":[{"award-number":["CA016672"]}]},{"name":"Monteleone Family Foundation"},{"DOI":"10.13039\/100010582","name":"NCI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010582","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ken and Bonnie Urologic Oncology Fund"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.urolonc.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T01:38:33Z","timestamp":1545442713000},"page":"292.e1-292.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma"],"prefix":"10.1016","volume":"37","author":[{"given":"Firas G.","family":"Petros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy N.","family":"Clinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Robyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay D.","family":"Raman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly","family":"Margulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-1445","authenticated-orcid":false,"given":"Surena F.","family":"Matin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2018.12.002_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology Guidelines on upper urinary tract Urothelial carcinoma: 2017 update","volume":"73","author":"Roupret","year":"2018","journal-title":"Eur Urol."},{"key":"10.1016\/j.urolonc.2018.12.002_bib0002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0090-4295(97)00230-6","article-title":"Upper-tract transitional cell carcinoma","volume":"50","author":"Tawfiek","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0003","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.urolonc.2017.05.009","article-title":"Optimizing management of upper tract urothelial carcinoma","volume":"35","author":"Campbell","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0004","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/cncr.24135","article-title":"Outcomes of radical nephroureterectomy: a series from the upper tract urothelial carcinoma collaboration","volume":"115","author":"Margulis","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","article-title":"Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients","volume":"52","author":"Hall","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0006","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/cncr.25043","article-title":"Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy","volume":"116","author":"Lane","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0007","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0008","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/cncr.25050","article-title":"Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma","volume":"116","author":"Matin","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0009","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2014.03.003","article-title":"A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma","volume":"66","author":"Leow","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0010","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.28655","article-title":"Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma","volume":"120","author":"Porten","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0011","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.juro.2010.03.142","article-title":"Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract","volume":"184","author":"Margulis","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0012","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.urolonc.2013.08.029","article-title":"Highlights from the first symposium on upper tract urothelial carcinoma","volume":"32","author":"Matin","year":"2014","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0013","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0014","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0015","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/00000478-199812000-00001","article-title":"The World Health Organization\/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee","volume":"22","author":"Epstein","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0016","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0017","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0022-1759(95)00078-O","article-title":"Two-graph receiver operating characteristic (TG-ROC): a Microsoft-EXCEL template for the selection of cut-off values in diagnostic tests","volume":"185","author":"Greiner","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0018","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0090-4295(00)00800-1","article-title":"Limitations of computed tomography in the preoperative staging of upper tract urothelial carcinoma","volume":"56","author":"Scolieri","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0019","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1097\/PAS.0b013e3181aec42a","article-title":"Small endoscopic biopsies of the ureter and renal pelvis: pathologic pitfalls","volume":"33","author":"Tavora","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0020","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/j.1464-410X.2011.10075.x","article-title":"Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the upper tract urothelial carcinoma collaboration","volume":"108","author":"Youssef","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0021","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.urolonc.2016.11.018","article-title":"Neoadjuvant and adjuvant chemotherapy use in upper tract urothelial carcinoma","volume":"35","author":"Cohen","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0022","first-page":"e1166","article-title":"Phase II trial of neoadjuvant chemotherapy followed by extirpative surgery for patients with high grade upper tract urothelial carcinoma: results from ECOG-ACRIN 8141","volume":"199","author":"Hoffman-Censits","year":"2018","journal-title":"J Uro, Supplement"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1464-410X.2011.10288.x","article-title":"Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma","volume":"109","author":"Favaretto","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0024","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.juro.2010.03.030","article-title":"Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma","volume":"184","author":"Brien","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2013.09.010","article-title":"Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy","volume":"191","author":"Rink","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0026","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.clgc.2015.03.007","article-title":"Prognostic impact of preoperative anemia on urothelial and extraurothelial recurrence in patients with upper tract urothelial carcinoma","volume":"13","author":"Milojevic","year":"2015","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0027","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.urolonc.2016.03.018","article-title":"Is preoperative anemia a risk factor for upper tract urothelial carcinoma following radical nephroureterectomy?","volume":"34","author":"Yeh","year":"2016","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0028","article-title":"Increased upper and lower tract urothelial carcinoma in patients with end-stage renal disease: a nationwide cohort study in Taiwan during 1997-2008","volume":"2014","author":"Wang","year":"2014","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.urolonc.2018.12.002_bib0029","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/0272-6386(95)90544-8","article-title":"Urologic cancers in uremic patients","volume":"25","author":"Chen","year":"1995","journal-title":"Am J Kidney Dis"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143918304940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143918304940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:15:53Z","timestamp":1761041753000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143918304940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1078143918304940"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.12.002","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative multiplex nomogram for prediction of high-risk nonorgan-confined upper-tract urothelial carcinoma","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}